Adapted generative latent diffusion models for accurate pathological analysis in chest X-ray images

Respiratory diseases have a significant global impact, and assessing these conditions is crucial for improving patient outcomes. Chest X-ray is widely used for diagnosis, but expert evaluation can be challenging. Automatic computer-aided diagnosis methods can provide support for clinicians in these tasks. Deep learning has emerged as a set of algorithms with exceptional potential in such tasks. However, these algorithms require a vast amount of data, often scarce in medical imaging domains. In this work, a new data augmentation methodology based on adapted generative latent diffusion models is proposed to improve the performance of an automatic pathological screening in two high-impact scenarios: tuberculosis and lung nodules. The methodology is evaluated using three publicly available datasets, representative of real-world settings. An ablation study obtained the highest-performing image generation model configuration regarding the number of training steps. The results demonstrate that the novel set of generated images can improve the performance of the screening of these two highly relevant pathologies, obtaining an accuracy of 97.09%, 92.14% in each dataset of tuberculosis screening, respectively, and 82.19% in lung nodules. The proposal notably improves on previous image generation methods for data augmentation, highlighting the importance of the contribution in these critical public health challenges.

WS-LungNet: A two-stage weakly-supervised lung cancer detection and diagnosis network

Computer-aided lung cancer diagnosis (CAD) system on computed tomography (CT) helps radiologists guide preoperative planning and prognosis assessment. The flexibility and scalability of deep learning methods are limited in lung CAD. In essence, two significant challenges to be solved are (1) Label scarcity due to cost annotations of CT images by experienced domain experts, and (2) Label inconsistency between the observed nodule malignancy and the patients' pathology evaluation. These two issues can be considered weak label problems. We address these issues in this paper by introducing a weakly-supervised lung cancer detection and diagnosis network (WS-LungNet), consisting of a semi-supervised computer-aided detection (Semi-CADe) that can segment 3D pulmonary nodules based on unlabeled data through adversarial learning to reduce label scarcity, as well as a cross-nodule attention computer-aided diagnosis (CNA-CADx) for evaluating malignancy at the patient level by modeling correlations between nodules via cross-attention mechanisms and thereby eliminating label inconsistency. Through extensive evaluations on the LIDC-IDRI public database, we show that our proposed method achieves 82.99% competition performance metric (CPM) on pulmonary nodule detection and 88.63% area under the curve (AUC) on lung cancer diagnosis. Extensive experiments demonstrate the advantage of WS-LungNet on nodule detection and malignancy evaluation tasks. Our promising results demonstrate the benefits and flexibility of the semi-supervised segmentation with adversarial learning and the nodule instance correlation learning with the attention mechanism. The results also suggest that making use of the unlabeled data and taking the relationship among nodules in a case into account are essential for lung cancer detection and diagnosis.

Learning from pseudo-lesion: a self-supervised framework for COVID-19 diagnosis

The Coronavirus disease 2019 (COVID-19) has rapidly spread all over the world since its first report in December 2019, and thoracic computed tomography (CT) has become one of the main tools for its diagnosis. In recent years, deep learning-based approaches have shown impressive performance in myriad image recognition tasks. However, they usually require a large number of annotated data for training. Inspired by ground glass opacity, a common finding in COIVD-19 patient's CT scans, we proposed in this paper a novel self-supervised pretraining method based on pseudo-lesion generation and restoration for COVID-19 diagnosis. We used Perlin noise, a gradient noise based mathematical model, to generate lesion-like patterns, which were then randomly pasted to the lung regions of normal CT images to generate pseudo-COVID-19 images. The pairs of normal and pseudo-COVID-19 images were then used to train an encoder-decoder architecture-based U-Net for image restoration, which does not require any labeled data. The pretrained encoder was then fine-tuned using labeled data for COVID-19 diagnosis task. Two public COVID-19 diagnosis datasets made up of CT images were employed for evaluation. Comprehensive experimental results demonstrated that the proposed self-supervised learning approach could extract better feature representation for COVID-19 diagnosis, and the accuracy of the proposed method outperformed the supervised model pretrained on large-scale images by 6.57% and 3.03% on SARS-CoV-2 dataset and Jinan COVID-19 dataset, respectively.

Robust and accurate pulmonary nodule detection with self-supervised feature learning on domain adaptation

Medical imaging data annotation is expensive and time-consuming. Supervised deep learning approaches may encounter overfitting if trained with limited medical data, and further affect the robustness of computer-aided diagnosis (CAD) on CT scans collected by various scanner vendors. Additionally, the high false-positive rate in automatic lung nodule detection methods prevents their applications in daily clinical routine diagnosis. To tackle these issues, we first introduce a novel self-learning schema to train a pre-trained model by learning rich feature representatives from large-scale unlabeled data without extra annotation, which guarantees a consistent detection performance over novel datasets. Then, a 3D feature pyramid network (3DFPN) is proposed for high-sensitivity nodule detection by extracting multi-scale features, where the weights of the backbone network are initialized by the pre-trained model and then fine-tuned in a supervised manner. Further, a High Sensitivity and Specificity (HS2 ) network is proposed to reduce false positives by tracking the appearance changes among continuous CT slices on Location History Images (LHI) for the detected nodule candidates. The proposed method's performance and robustness are evaluated on several publicly available datasets, including LUNA16, SPIE-AAPM, LungTIME, and HMS. Our proposed detector achieves the state-of-the-art result of 90.6 % sensitivity at 1 / 8 false positive per scan on the LUNA16 dataset. The proposed framework's generalizability has been evaluated on three additional datasets (i.e., SPIE-AAPM, LungTIME, and HMS) captured by different types of CT scanners.

Identification of pathological subtypes of early lung adenocarcinoma based on artificial intelligence parameters and CT signs

Objective: To explore the value of quantitative parameters of artificial intelligence (AI) and computed tomography (CT) signs in identifying pathological subtypes of lung adenocarcinoma appearing as ground-glass nodules (GGNs). Methods: CT images of 224 GGNs from 210 individuals were collected retrospectively and classified into atypical adenomatous hyperplasia (AAH)/adenocarcinoma in situ (AIS), minimally invasive adenocarcinoma (MIA), and invasive adenocarcinoma (IAC) groups. AI was used to identify GGNs and to obtain quantitative parameters, and CT signs were recognized manually. The mixed predictive model based on logistic multivariate regression was built and evaluated. Results: Of the 224 GGNs, 55, 93, and 76 were AAH/AIS, MIA, and IAC, respectively. In terms of AI parameters, from AAH/AIS to MIA, and IAC, there was a gradual increase in two-dimensional mean diameter, three-dimensional mean diameter, mean CT value, maximum CT value, and volume of GGNs (all P<0.0001). Except for the CT signs of the location, and the tumor–lung interface, there were significant differences among the three groups in the density, shape, vacuolar signs, air bronchogram, lobulation, spiculation, pleural indentation, and vascular convergence signs (all P<0.05). The areas under the curve (AUC) of predictive model 1 for identifying the AAH/AIS and MIA and model 2 for identifying MIA and IAC were 0.779 and 0.918, respectively, which were greater than the quantitative parameters independently (all P<0.05). Conclusion: AI parameters are valuable for identifying subtypes of early lung adenocarcinoma and have improved diagnostic efficacy when combined with CT signs.

A systematic review and meta-analysis of diagnostic performance and physicians' perceptions of artificial intelligence (AI)-assisted CT diagnostic technology for the classification of pulmonary nodules

Background

Lung cancer was the second most commonly diagnosed cancer and the leading cause of cancer death in 2020. Although artificial intelligence (AI)-assisted diagnostic technologies have shown promise and has been used in clinical practice in recent years, no products related to AI-assisted CT diagnostic technologies for the classification of pulmonary nodules have been approved by the National Medical Products Administration in China. The objective of this article was to systematically review the diagnostic performance of AI-assisted CT diagnostic technology for the classification of pulmonary nodules as benign or malignant and to analyze physicians’ perceptions of this technology in China.

Methods

All relevant studies from 6 literature databases were searched and screened according to the inclusion and exclusion criteria. Data were extracted and the study quality was assessed by two reviewers. The study heterogeneity and publication bias were estimated. A questionnaire survey on the perceptions of physicians was conducted in 9 public tertiary hospitals in China. A meta-analysis, meta-regression and univariate logistic model were used in the systematic review and to explore the association of physicians’ perceptions with their rate of support for the clinical application of the technology.

Results

Twenty-seven studies with 5,727 pulmonary nodules were finally included in the meta-analysis. We found that the quality of the included studies was generally acceptable and that the pooled sensitivity and specificity of AI-assisted CT diagnostic technology for the classification of pulmonary nodules as benign or malignant were 0.90 and 0.89, respectively. The pooled diagnostic odds ratio (DOR) was 70.33. The majority of the surveyed physicians in China perceived “reduced workload for radiologists” and “improved diagnostic efficiency” as the important benefits of this technology. In addition, diagnostic accuracy (including misdiagnosis) and practical experience were significantly associated with whether physicians supported its clinical application.

Conclusions

In the context of lung cancer diagnosis, AI-assisted CT diagnostic technology for the classification of pulmonary nodules as benign or malignant has good diagnostic performance, but its specificity needs to be improved.

A self-supervised feature-standardization-block for cross-domain lung disease classification

With the advance of deep learning technology, convolutional neural network (CNN) has been wildly used and achieved the state-of-the-art performances in the area of medical image classification. However, most existing medical image classification methods conduct their experiments on only one public dataset. When applying a well-trained model to a different dataset selected from different sources, the model usually shows large performance degradation and needs to be fine-tuned before it can be applied to the new dataset. The goal of this work is trying to solve the cross-domain image classification problem without using data from target domain. In this work, we designed a self-supervised plug-and-play feature-standardization-block (FSB) which consisting of image normalization (INB), contrast enhancement (CEB) and boundary detection blocks (BDB), to extract cross-domain robust feature maps for deep learning framework, and applied the network for chest x-ray-based lung diseases classification. Three classic deep networks, i.e. VGG, Xception and DenseNet and four chest x-ray lung diseases datasets were employed for evaluating the performance. The experimental result showed that when employing feature-standardization-block, all three networks showed better domain adaption performance. The image normalization, contrast enhancement and boundary detection blocks achieved in average 2%, 2% and 5% accuracy improvement, respectively. By combining all three blocks, feature-standardization-block achieved in average 6% accuracy improvement.

Lung cancer identification: a review on detection and classification

Lung cancer is one of the most common diseases among humans and one of the major causes of growing mortality. Medical experts believe that diagnosing lung cancer in the early phase can reduce death with the illustration of lung nodule through computed tomography (CT) screening. Examining the vast amount of CT images can reduce the risk. However, the CT scan images incorporate a tremendous amount of information about nodules, and with an increasing number of images make their accurate assessment very challenging tasks for radiologists. Recently, various methods are evolved based on handcraft and learned approach to assist radiologists. In this paper, we reviewed different promising approaches developed in the computer-aided diagnosis (CAD) system to detect and classify the nodule through the analysis of CT images to provide radiologists' assistance and present the comprehensive analysis of different methods.

Versatile role of curcumin and its derivatives in lung cancer therapy

Lung cancer is a main cause of death all over the world with a high incidence rate. Metastasis into neighboring and distant tissues as well as resistance of cancer cells to chemotherapy demand novel strategies in lung cancer therapy. Curcumin is a naturally occurring nutraceutical compound derived from Curcuma longa (turmeric) that has great pharmacological effects, such as anti-inflammatory, neuroprotective, and antidiabetic. The excellent antitumor activity of curcumin has led to its extensive application in the treatment of various cancers. In the present review, we describe the antitumor activity of curcumin against lung cancer. Curcumin affects different molecular pathways such as vascular endothelial growth factors, nuclear factor-κB (NF-κB), mammalian target of rapamycin, PI3/Akt, microRNAs, and long noncoding RNAs in treatment of lung cancer. Curcumin also can induce autophagy, apoptosis, and cell cycle arrest to reduce the viability and proliferation of lung cancer cells. Notably, curcumin supplementation sensitizes cancer cells to chemotherapy and enhances chemotherapy-mediated apoptosis. Curcumin can elevate the efficacy of radiotherapy in lung cancer therapy by targeting various signaling pathways, such as epidermal growth factor receptor and NF-κB. Curcumin-loaded nanocarriers enhance the bioavailability, cellular uptake, and antitumor activity of curcumin. The aforementioned effects are comprehensively discussed in the current review to further direct studies for applying curcumin in lung cancer therapy.

Applications and strategies in nanodiagnosis and nanotherapy in lung cancer

Lung cancer is the second most common cancer and the leading cause of death in both men and women in the world. Lung cancer is heterogeneous in nature and diagnosis is often at an advanced stage as it develops silently in the lung and is frequently associated with high mortality rates. Despite the advances made in understanding the biology of lung cancer, progress in early diagnosis, cancer therapy modalities and considering the mechanisms of drug resistance, the prognosis and outcome still remains low for many patients. Nanotechnology is one of the fastest growing areas of research that can solve many biological problems such as cancer. A growing number of therapies based on using nanoparticles (NPs) have successfully entered the clinic to treat pain, cancer, and infectious diseases. Recent progress in nanotechnology has been encouraging and directed to developing novel nanoparticles that can be one step ahead of the cancer reducing the possibility of multi-drug resistance. Nanomedicine using NPs is continuingly impacting cancer diagnosis and treatment. Chemotherapy is often associated with limited targeting to the tumor, side effects and low solubility that leads to insufficient drug reaching the tumor. Overcoming these drawbacks of chemotherapy by equipping NPs with theranostic capability which is leading to the development of novel strategies. This review provides a synopsis of current progress in theranostic applications for lung cancer diagnosis and therapy using NPs including liposome, polymeric NPs, quantum dots, gold NPs, dendrimers, carbon nanotubes and magnetic NPs.

Multi-resolution convolutional networks for chest X-ray radiograph based lung nodule detection

Lung cancer is the leading cause of cancer death worldwide. Early detection of lung cancer is helpful to provide the best possible clinical treatment for patients. Due to the limited number of radiologist and the huge number of chest x-ray radiographs (CXR) available for observation, a computer-aided detection scheme should be developed to assist radiologists in decision-making. While deep learning showed state-of-the-art performance in several computer vision applications, it has not been used for lung nodule detection on CXR. In this paper, a deep learning-based lung nodule detection method was proposed. We employed patch-based multi-resolution convolutional networks to extract the features and employed four different fusion methods for classification. The proposed method shows much better performance and is much more robust than those previously reported researches. For publicly available Japanese Society of Radiological Technology (JSRT) database, more than 99% of lung nodules can be detected when the false positives per image (FPs/image) was 0.2. The FAUC and R-CPM of the proposed method were 0.982 and 0.987, respectively. The proposed approach has the potential of applications in clinical practice.

Thorax-Net: An Attention Regularized Deep Neural Network for Classification of Thoracic Diseases on Chest Radiography

Deep learning techniques have been increasingly used to provide more accurate and more accessible diagnosis of thorax diseases on chest radiographs. However, due to the lack of dense annotation of large-scale chest radiograph data, this computer-aided diagnosis task is intrinsically a weakly supervised learning problem and remains challenging. In this paper, we propose a novel deep convolutional neural network called Thorax-Net to diagnose 14 thorax diseases using chest radiography. Thorax-Net consists of a classification branch and an attention branch. The classification branch serves as a uniform feature extraction-classification network to free users from the troublesome hand-crafted feature extraction and classifier construction. The attention branch exploits the correlation between class labels and the locations of pathological abnormalities via analyzing the feature maps learned by the classification branch. Feeding a chest radiograph to the trained Thorax-Net, a diagnosis is obtained by averaging and binarizing the outputs of two branches. The proposed Thorax-Net model has been evaluated against three state-of-the-art deep learning models using the patientwise official split of the ChestX-ray14 dataset and against other five deep learning models using the imagewise random data split. Our results show that Thorax-Net achieves an average per-class area under the receiver operating characteristic curve (AUC) of 0.7876 and 0.896 in both experiments, respectively, which are higher than the AUC values obtained by other deep models when they were all trained with no external data.

Active Contour Based Segmentation and Classification for Pleura Diseases Based on Otsu’s Thresholding and Support Vector Machine (SVM)

Objective: Generally, lung cancer is the abnormal growth of cells that originates in one or both lungs. Finding the pulmonary nodule helps in the diagnosis of lung cancer in early stage and also increase the lifetime of the individual. Accurate segmentation of normal and abnormal portion in segmentation is challenging task in computer-aided diagnostics. Methods: The article proposes an innovative method to spot the cancer portion using Otsu’s segmentation algorithm. It is followed by a Support Vector Machine (SVM) classifier to classify the abnormal portion of the lung image. Results: The suggested methods use the Otsu’s thresholding and active contour based segmentation techniques to locate the affected lung nodule of CT images. The segmentation is followed by an SVM classifier in order to categorize the affected portion is normal or abnormal. The proposed method is suitable to provide good and accurate segmentation and classification results for complex images. Conclusion: The comparative analysis between the two segmentation methods along with SVM classifier was performed. A classification process based on active contour and SVM techniques provides better than Otsu’s segmentation for complex lung images.

An Appraisal of Lung Nodules Automatic Classification Algorithms for CT Images

Lung cancer is one of the most deadly diseases around the world representing about 26% of all cancers in 2017. The five-year cure rate is only 18% despite great progress in recent diagnosis and treatment. Before diagnosis, lung nodule classification is a key step, especially since automatic classification can help clinicians by providing a valuable opinion. Modern computer vision and machine learning technologies allow very fast and reliable CT image classification. This research area has become very hot for its high efficiency and labor saving. The paper aims to draw a systematic review of the state of the art of automatic classification of lung nodules. This research paper covers published works selected from the Web of Science, IEEEXplore, and DBLP databases up to June 2018. Each paper is critically reviewed based on objective, methodology, research dataset, and performance evaluation. Mainstream algorithms are conveyed and generic structures are summarized. Our work reveals that lung nodule classification based on deep learning becomes dominant for its excellent performance. It is concluded that the consistency of the research objective and integration of data deserves more attention. Moreover, collaborative works among developers, clinicians, and other parties should be strengthened.

X-Ray Enhancement Based on Component Attenuation, Contrast Adjustment, and Image Fusion

Inspecting X-ray images is an essential aspect of medical diagnosis. However, due to an X-ray's low contrast and low dynamic range, important aspects such as organs, bones, and nodules become difficult to identify. Hence, contrast adjustment is critical, especially because of its ability to enhance the details in both bright and dark regions. For X-ray image enhancement, we therefore propose a new concept based on component attenuation. Notably, we assumed an X-ray image could be decomposed into tissue components and important details. Since tissues may not be the major primary focus of an X-ray, we proposed enhancing the visual contrast by adaptive tissue attenuation and dynamic range stretching. Via component decomposition and tissue attenuation, a parametric adjustment model was deduced to generate many enhanced images at once. Finally, an ensemble framework was proposed for fusing these enhanced images and producing a high-contrast output in both bright and dark regions. We have used measurement metrics to evaluate our system and achieved promising scores in each. An online testing system was also built for subjective evaluation. Moreover, we applied our system to an X-ray data set provided by the Japanese Society of Radiological Technology to help with nodule detection. The experimental results of which demonstrated the effectiveness of our method.